Increased patient age is associated with unfavorable prognostic features, as previously demonstrated in smaller cohorts.32,33 Older patients were more likely to have higher-grade tumors (oligodendroglioma, and astrocytomas) and disadvantageous PDGFRA alterations (glioblastoma). Here, PDGFRA is linked to astrocytoma (excluding glioblastoma).